speb/financial-data huggingface dataset:
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 23803900000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 8700000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 67800000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 358000000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1177300000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1098600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Normalized Income: -442500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 140000000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Operating Income: -362800000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Operating Revenue: 17376300000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 129100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 2231552000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 561379000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 30600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 563600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 329600000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 219900000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 214500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 8696000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 4200000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1712100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Payable: 522000000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Properties: 11944269000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 172700000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 13400000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Other Special Charges: 559800000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Payables: 4069600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1879800000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Pretax Income: -849600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 1262600000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -225500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 2888000000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 8641300000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1231600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 15500000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 15500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -256600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Research And Development: 251400000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 34100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 23157700000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 652300000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 89500000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1839200000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2324600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Share Issued: 70405750.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Special Income Charges: -559800000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 30800000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 24383000000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 23803900000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Tax Provision: 88000000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -63700000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Assets: 32749500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 24765200000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2475200000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 24383000000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Total Expenses: 17739100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 8366500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 15316300000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 990500000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 5100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 22100000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -495100000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -495100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Work In Process: 1027300000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Working Capital: 10057200000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 3617800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 6303900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 61100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 318500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1877800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1984200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 24006500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 1450600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 18234700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 58800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 2427700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 2486500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 8196000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 1413600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 15500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 15500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 12964300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 8374600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 26689000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 61100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 259700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 254800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 514500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 386000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 804700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 12964300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 23991000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1484700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 238500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 23865700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1769500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 6400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 11513700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 106400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Payables: 3617800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 70405750.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 24006500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 23991000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 86700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 33109600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 24261300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 3001000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 24006500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 9103100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 14874900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 907100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 10038700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — +Operating Expense: 9288700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 2686000000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — +Total Revenue: 20644800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 5871800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 3869400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3869400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 7788100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7788100000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -6787400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6787400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 137900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 137900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -53800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -53800000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Amortization: 112300000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 112300000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 82900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 82900000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 70405750.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 70438830.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Basic EPS: 19.53
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 7.52
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1547500000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 5715100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 5715100000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1373600000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 298000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 298000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 895800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 895800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 895800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 895800000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -3400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 631700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 631700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 264100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 264100000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -2524800000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Change In Payable: -23700000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -390400000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -2938900000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -644900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 24505900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 24505900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 520200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 520200000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 9953100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2645700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Current Assets: 20294700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 20294700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 46100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 46100000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt: 3691600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 3691600000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 3737700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3737700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 9919700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 9919700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 1376400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1376400000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Depreciation: 1133300000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1245600000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1245600000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 296900000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1133300000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 296900000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 70621312.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 70626667.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Diluted EPS: 19.47
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 7.50
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1375200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 529700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 9500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 9500000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — EBIT: 1752900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — EBIT: 632600000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — EBITDA: 2998500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — EBITDA: 929500000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — End Cash Position: 895800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 200000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 1837600000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 4982200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 4982200000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -1443800000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 6600000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -9500000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 510700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill: 15500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 15500000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 202500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 202500000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 7841900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 7841900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 20100800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 20100800000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Gross Profit: 10691700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 3226100000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Interest Expense: 207000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 54600000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 207000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 54600000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Interest Income: 28500000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 28500000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -195700000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 16900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Inventory: 9887400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 9887400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 28805600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 28805600000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -2412300000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 200000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 0.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 503900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 504000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 504000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Liabilities Heldfor Sale Non Current: 46800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Liabilities Heldfor Sale Non Current: 46800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 251900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 251900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 608100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 608100000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 860000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 860000000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 503900000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -256600000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 378600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 378600000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 13361500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 13361500000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -844500000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Net Debt: 3403900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 3403900000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 40100000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Income: 1375200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Income: 529700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1375200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 529700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1375200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 529700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1375200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 529700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1375200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 529700000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1545900000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1375200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 529700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Interest Income: -181800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -54600000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 13600000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 2095700000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 247300000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -181800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -54600000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -246400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Net PPE: 13313400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 13313400000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1351900000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 1848400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 24303400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 24303400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 6400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 6400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 257800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 257800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 378600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 378600000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1291200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1291200000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 2896400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 929500000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Normalized Income: 1284373995.73
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 529700000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -70200000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Operating Income: 1403000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Operating Income: 540100000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Operating Revenue: 20644800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 5871800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -6800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1394000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1394000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 229900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 229900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 51200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 51200000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 187000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 187000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 300800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 300800000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 181800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 248000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 248000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -23400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -23400000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 7000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 92500000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1931300000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1424400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Payable: 849400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 849400000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Properties: 12793200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 12793200000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 228900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 228900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 328800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 328800000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Other Special Charges: -9500000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Payables: 4771700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Payables: 4771700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1214000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1214000000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Pretax Income: 1545900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 578000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 14100000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -844500000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1373600000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 3438100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 3438100000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 9953100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2645700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1245600000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 296900000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 17600000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 17600000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -256600000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Research And Development: 185100000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 280500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 280500000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 24561800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 24561800000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 13600000.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 21700000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 2020100000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2530800000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Share Issued: 70405750.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 70405750.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Special Income Charges: 9500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 21200000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 24505900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 24505900000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 24303400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 24303400000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 11273995.73
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Tax Provision: 170700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 48300000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.11
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.08
UNICHEMLAB.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -164200000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Assets: 35694000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 35694000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 25114000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 25114000000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Debt: 4597700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 4597700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 24505900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 24505900000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Total Expenses: 19241800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 5331700000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 11188100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11188100000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 15399300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15399300000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1268400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1268400000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 3300000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 43400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 43400000.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 102100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
UNICHEMLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 102100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Work In Process: 1166300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 1166300000.00
UNICHEMLAB.NS balance_sheet (annual, 2025-03-31) — Working Capital: 10375000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 10375000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 2908500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 5266000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 70268456.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -1.49
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2450500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 317900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 317900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 70268456.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.49
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — EBIT: -24800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — EBITDA: 293100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 2815500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 65400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 65400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Income: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -65400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -65400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 293100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -104700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Operating Income: -93000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 5266000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 68200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1516400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -90200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2450500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 317900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 14500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 5359000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 2738700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 5789600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3184200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7778600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 88100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 70355030.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -1.69
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 284500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1780300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1937400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 24348400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 788800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2703800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 20259600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 46100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 4302200000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4348300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 10166000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 1812000000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 314700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 314700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 70355030.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.69
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -118900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — EBIT: -25800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — EBITDA: 288900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 15500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 165900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 13085600000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 3085800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 82400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 82400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 9779000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 29083500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 88100000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Liabilities Heldfor Sale Non Current: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 238400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 432900000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 671300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 372300000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2954800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Income: -118900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -118900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -118900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -118900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -118900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -118900000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -82400000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -82400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 13085600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 24182500000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 266600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 0.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 871500000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 288920000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Operating Income: 347100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 5789600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 764000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 363000000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 24207600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 150400000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1640800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 209700000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1422700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 12296800000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 600000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 157100000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Payables: 3188800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -108200000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2703800000.00
UNICHEMLAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 314700000.00
UNICHEMLAB.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 70405750.00